BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 508779)

  • 1. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minos-insertion mutant of the Drosophila GBA gene homologue showed abnormal phenotypes of climbing ability, sleep and life span with accumulation of hydroxy-glucocerebroside.
    Kawasaki H; Suzuki T; Ito K; Takahara T; Goto-Inoue N; Setou M; Sakata K; Ishida N
    Gene; 2017 May; 614():49-55. PubMed ID: 28286087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher's disease: a case history with extensive lipid storage in the brain.
    Leech RW; Shuman RM; Putnam WD; Rance F; Jewett TT
    Am J Clin Pathol; 1985 Apr; 83(4):516-9. PubMed ID: 3984948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical research of a new therapy for Gaucher's disease with F213I mutation].
    Hou L; Kousaku O
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):381-4. PubMed ID: 14556188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    Glew RH; Gopalan V; Hubbell CA; Devraj RV; Lawson RA; Diven WF; Mannock DA
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE.
    BRADY RO; KANFER J; SHAPIRO D
    J Biol Chem; 1965 Jan; 240():39-43. PubMed ID: 14253443
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucocerebroside storage in normal monocyte cultures.
    Hardy B; Teitelman-Weissman B; Chazan S; Neri A
    Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined gas chromatography-chemical ionization mass spectrometry of sphingolipids. I. Glucosyl sphingosine, ceramides and cerebrosides of the spleen in Gaucher's disease.
    Oshima M; Ariga T; Murata T
    Chem Phys Lipids; 1977 Aug; 19(4):289-99. PubMed ID: 908103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.
    BRADY RO; KANFER JN; SHAPIRO D
    Biochem Biophys Res Commun; 1965 Jan; 18():221-5. PubMed ID: 14282020
    [No Abstract]   [Full Text] [Related]  

  • 15. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease.
    Kitatani K; Wada M; Perry D; Usui T; Sun Y; Obeid LM; Yaegashi N; Grabowski GA; Hannun YA
    PLoS One; 2015; 10(8):e0136633. PubMed ID: 26312487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher's disease, a review.
    Peters SP; Lee RE; Glew RH
    Medicine (Baltimore); 1977 Sep; 56(5):425-42. PubMed ID: 329054
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons from glucosylceramide and Gaucher's disease.
    Luft FC
    J Mol Med (Berl); 1998 Oct; 76(11):723-4. PubMed ID: 9826117
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone-marrow transplantation in severe Gaucher's disease.
    Rappeport JM; Ginns EI
    N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.
    Brady RO; Kanfer JN; Bradley RM; Shapiro D
    J Clin Invest; 1966 Jul; 45(7):1112-5. PubMed ID: 5338605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.